Clinical Trial Update: Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluating immunotherapy in combination with a second drug in patients with progressive advanced mucosal cancers at multiple sites.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Cervical Cancer
• Head and Neck Squamous Cell Carcinoma
• Penile Cancer
• Squamous Cell Lung Cancer
• Vulvar Cancer

Snippet

Sponsor: UNICANCER | Conditions: Squamous Cell Lung Cancer, Vulvar Cancer | Phase 2 | Status: COMPLETED